Anti-GD2 CAR T Cells Are Potent in H3-K27M+ Diffuse Midline Gliomas [Research Watch]

The disialoganglioside GD2 is an immunotherapeutic target in H3-K27M⁺ diffuse midline gliomas.

from Cancer via ola Kala on Inoreader https://ift.tt/2r5Sur0
via IFTTT